Abstract
Editorial: Biology-Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future Challenges.
Highlights
Editorial: Biology-Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future Challenges
Recent reviews [5] and international expert congresses further emphasize the urgent need for a more rapid and especially more successful translational process [6,7,8] (Kovar et al, Schäfer et al.). This Frontiers Research Topic entitled “Biology-driven targeted therapy of pediatric soft-tissue and bone tumors: current opportunities and future challenges” was dedicated to this aspect and provided a transdisciplinary forum for researchers working at the interfaces between basic cell biology, tumorigenesis, and personalized medicine
Many excellent researchers have contributed to this topic covering the most common and rare sarcoma entities of this age group, such as osteosarcoma, Ewing sarcoma, rhabdomyosarcoma, and epithelioid sarcoma
Summary
Biology-Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future Challenges Editorial: Biology-Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future Challenges.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
